Tempus AI, Inc. experienced a notable increase in its stock price, reflecting positive market sentiment driven by recent developments in the AI healthcare sector.
Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM) surged by 7.38% yesterday, closing at CA$82.24. This increase is attributed to rising interest in AI-driven medical solutions and strategic partnerships that enhance the company's growth prospects.
Investor takeaway: Investors are encouraged by Tempus AI's strong revenue growth and strategic partnerships, positioning the company favorably within the expanding AI healthcare market.
Advertisement
Tempus AI, Inc. Class A Common Stock
TEM.US
TEM.US
Tempus AI, Inc. Class A Common Stock
WealthAwesomeMarket cap
$14.84B
52W high
$104.32
52W low
$40.77
1W change
+2.34%
Beta
3.72
Analyst Price Targets
Based on 12 analysts covering TEM · as of Sep 23, 2026
Wall Street analysts forecast TEM stock price to fall 16.6% over the next 12 months.
Consensus
Buy3.83 / 5.00
Avg. Target
C$68.56
-16.6% Upside
Previously C$68.18 on Sep 17, 2026
Current Price
C$82.24
Last close
Analyst Breakdown (12 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TEM's historical volatility
30-Day Vol
104.5%
Annualized
90-Day Vol
88.3%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$98.32
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$87.28 | C$60.86 – C$125.19 |
| 60 trading days | C$92.64 | C$55.63 – C$154.28 |
| 90 trading days | C$98.32 | C$52.64 – C$183.62 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
7.38% Surge in Stock Price
Tempus AI's stock price increase reflects strong market confidence in its AI-driven healthcare solutions and recent strategic partnerships.
Bull case
The company's revenue growth, especially in diagnostics and data applications, shows a strong demand for its AI solutions. With expected earnings growth rates of 55.7% this year, Tempus AI is well-positioned to take advantage of the growing need for precision medicine.
Bear case
Despite the positive growth, there are concerns about the sustainability of revenue from its data and applications segment, particularly with several major contracts nearing renewal. Investors should keep a close eye on these developments.
Strong Revenue Growth Drives Investor Confidence
Advertisement
Tempus AI reported a 22% year-over-year increase in revenue for the second quarter, reaching $382.5 million. This growth was largely fueled by a 31% rise in oncology testing volumes, highlighting the company's ability to use AI for better patient outcomes. This strong performance has drawn investor attention, contributing to the recent surge in stock price.
Strategic Partnerships Enhance Market Position
The extension of Tempus's partnership with Recursion Pharmaceuticals, along with new agreements, shows the company's commitment to advancing precision medicine. These collaborations not only boost Tempus's capabilities but also provide a steady revenue stream, further strengthening its position in the competitive healthcare landscape.
Future Growth Potential Amidst Challenges
While Tempus AI's current growth trajectory looks promising, investors should remain cautious about the upcoming contract renewals in its data and applications segment. The company needs to prove that its growth can continue beyond the initial momentum to maintain investor confidence and support its stock price.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
